)
26 October 2022
The International Pharmaceutical Federation (FIP) today launched a new practice support handbook for pharmacists on cardiovascular disease (CVD) services.
“Cardiovascular diseases: A handbook for pharmacists” covers prevention, care and management roles, including: health promotion and education; early detection; triage and referral; interprofessional collaborative practice; disease management (including medication adherence); treatment optimisation; and helping to shape public policies. In particular, it contains a chapter on practice-based research.
“Care goes beyond medicines use and optimising effectiveness and safety. Pharmacists can also be
involved in practice-based research to evaluate the impact of CVD services. This new handbook contains several evidence-based interventions by pharmacists around the world that have led to positive health and economic outcomes for patients, which readers will find valuable and inspirational,” said Dr. Inês Nunes da Cunha, FIP practice development and transformation projects manager and lead author of the handbook.
The new handbook has been developed in collaboration with the World Heart Federation (WHF) and the European Society of Clinical Pharmacy. In a foreword to the handbook, WHF president Professor Fausto Pinto writes: “The pharmaceutical workforce is an essential pillar of the healthcare system and is ideally positioned to strengthen primary care delivery…This is particularly true for CVD, which can often be addressed by simple, affordable interventions that can be delivered in the pharmacy setting.”
Further Information:
)
The G20 Health & Development Partnership (G20HDP) has this month issued a Call to Action to wealthy countries to do more to tackle cardiovascular disease around the world.
The Declaration of the G20 Health Ministers (5-6 September 2021) acknowledges[1] “[...]that non-communicable diseases such as cancer, cardiovascular disease (...)